Selective protection of the gastrointestinal tract against methotrexate in the treatment of patients with trophoblastic tumors.
D002244:Carbon / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D014677:Pharmaceutical Vehicles; D011247:Pregnancy; D013535:Suspensions; D014328:Trophoblastic Neoplasms / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D014677:Pharmaceutical Vehicles; D013535:Suspensions; D002244:Carbon; D005492:Folic Acid; D008727:Methotrexate